Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Piezo1-mediated stellate cell activation causes pressure-induced pancreatic fibrosis in mice
Sandip M. Swain, Joelle M-J Romac, Steven R. Vigna, Rodger A. Liddle
Sandip M. Swain, Joelle M-J Romac, Steven R. Vigna, Rodger A. Liddle
View: Text | PDF
Research Article Gastroenterology

Piezo1-mediated stellate cell activation causes pressure-induced pancreatic fibrosis in mice

  • Text
  • PDF
Abstract

Pancreatic fibrosis is a complication of chronic pancreatitis and is a prominent feature of pancreatic cancer. Pancreatic fibrosis is commonly observed in patients with prolonged pancreatic duct obstruction, which elevates intrapancreatic pressure. We show here that increased pancreatic duct pressure causes fibrosis and describes the mechanism by which pressure increases deposition of extracellular matrix proteins and fibrosis. We found that pancreatic stellate cells (PSCs), the source of the extracellular matrix proteins in fibrosis, express the mechanically activated ion channel Piezo1. By increasing intracellular calcium, mechanical stress or the Piezo1 agonist Yoda1-activated PSCs manifest by loss of perinuclear fat droplets and increased TGF-β1, fibronectin, and type I collagen expression. These effects were blocked by the Piezo1 inhibitor GsMTx4 and absent in PSCs from mice with conditional genetic deletion of Piezo1 in stellate cells, as was pancreatic duct ligation–induced fibrosis. Although TRPV4 has been proposed to have direct mechanosensing properties, we discovered that PSCs from Trpv4-KO mice were protected against Yoda1-triggered activation. Moreover, mice devoid of TRPV4 were protected from pancreatic duct ligation–induced fibrosis. Thus, high pressure within the pancreas stimulates Piezo1 channel opening, and subsequent activation of TRPV4 leads to stellate cell activation and pressure-induced chronic pancreatitis and fibrosis.

Authors

Sandip M. Swain, Joelle M-J Romac, Steven R. Vigna, Rodger A. Liddle

×

Figure 6

Piezo1 mediates TRPV4 channel opening in pancreatic stellate cells.

Options: View larger image (or click on image) Download as PowerPoint
Piezo1 mediates TRPV4 channel opening in pancreatic stellate cells.
(A) ...
(A) Immunostaining of GFAP and TRPV4 in human PSCs. (B) TRPV4 agonist GSK101 (100 nM) effects on [Ca2+]i in human PSCs with and without the TRPV4 blocker HC067 (1 μM). (C) GSK101 (100 nM) effects on [Ca2+]i in PSCs from 3 biological samples were blocked with the TRPV4 antagonist HC067 (1 μM) (from 18 to 37 cells). (D) Immunostaining of GFAP and TRPV4 in mouse PSCs. (E and F) Traces and graph represent the effects of the TRPV4 agonist GSK101 (100 nM) on [Ca2+]i in mouse PSCs with and without the TRPV4 blocker HC067 (1 μM) (from 18 cells). (G–I) Effects of Yoda1 (25 μM) on [Ca2+]i in PSCs from WT and TRPV4-KO mice. (I) Statistical analyses of peak and sustained [Ca2+]i elevation (from 24 to 32 cells). The sustained [Ca2+]i elevation was measured at 6 minutes after Yoda1. (J and K) Effects of phospholipase A2 blockers AACOCF3 (30 μM) and YM26734 (10 μM) on Yoda1-induced (25 μM) [Ca2+]i in PSCs (from 24 to 26 cells). The sustained calcium rise was measured at 8 minutes after Yoda1 application. (L–N) Fluid shear stress (12 dyne/cm2) was applied for 1 minute in PSCs from WT and TRPV4-KO mice and TRPV4-KO mice with GsMTx4 (5 μM). In panels G, H, and L–N, each colored line represents the response of a single cell. (O) Quantification of peak [Ca2+]i following shear stress (12 dyne/cm2) for 1 minute in TRPV4-KO PSCs with and without GsMTx4 (from 24 cells). Statistical analyses were calculated using 2-tailed Student’s t test. *P ≤ 0.05 and ****P ≤ 0.0001. Scale bar: 10 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts